Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Origin Agritech Receives GMO Safety Certificate for its Triple Stack Maize


Commercial Rollout to Begin Shortly

BEIJING, May 9, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the issuance of a GMO safety certificate for its transgenic maize, BBL2-2, marking a significant milestone for the Company and the agricultural sector, heralding a new era in crop innovation.

The newly certified BBL2-2 maize contains two insect-resistant genes, Cry1Ab and Cry3Bb, and one herbicide-tolerance gene, Cp4-epsps. This genetic composition makes the maize resistant to various lepidopteran pests such as corn borer, cotton bollworm, armyworm. BBL2-2 is a product with substantial commercial value and extensive application potential.

The certification of BBL2-2 confirms its adherence to stringent safety standards and paves the way for its commercial launch. The introduction of BBL2-2 is expected to significantly enhance agricultural productivity and sustainability, providing a powerful tool for farmers to manage pests more effectively and reduce the environmental impact of agriculture.

Dr. Gengchen Han, Chairman and CEO of Origin Agritech, commented, "Receiving this GMO safety certificate is a transformative moment for Origin Agritech and agricultural biotechnology in China. BBL2-2 exemplifies our capabilities in genetic innovation and sets a new standard in sustainable agriculture. We are eager to lead the commercialization of this technology, which promises significant improvements in crop resilience and yield."

In addition to its work on BBL2-2, Origin Agritech continues to advance its agricultural technology portfolio with significant progress in gene editing. Recently, the Company developed a high-yield corn inbred line through precise gene editing techniques, which has shown a yield increase of more than 50% over traditional corn in extensive multilocational field trials. The gene-edited event is now in the process of agricultural biosafety assessment. This development is expected to greatly enhance the productivity and cost-effectiveness of corn production, reinforcing Origin's commitment to sustainable and efficient agriculture.

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered in Zhong-Guan-Cun (ZGC) Life Science Park in Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and pest resistance (Bt) traits. For further information, please visit the Company's website at www.originagritech.com. The Company also maintains a Twitter account for updating investors on Company and industry developments which is https://x.com/origin_agritech.

Forward-Looking Statements

This communication contains "forward-looking statements" as defined in the federal securities laws, including Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements address expected future business and financial performance and financial condition and contain words like "expect," "anticipate," "intend," "plan," "believe," "seek," "will," "would," "target," and similar expressions and variations. Forward-looking statements address matters that are uncertain. Forward-looking statements are not guarantees of future performance and are based on assumptions and expectations that may not be realized. They are based on management's current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates but involve a number of risks and uncertainties, many of which are beyond the Company's control. Some of the important factors that could cause the Company's actual results to differ materially from those discussed in forward-looking statements are: failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting our products; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; natural disasters and weather events and patterns; ability to protect and enforce the Company's intellectual property rights; and separation of underperforming or non-strategic assets or businesses. The Company undertakes no duty or obligation to publicly revise or update any forward-looking statements as a result of future developments, new information, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. Actual results may differ materially from the anticipated results. You are urged to consider these factors carefully when evaluating the forward-looking statements contained herein. You are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.

For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: [email protected]

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: [email protected]

 

SOURCE Origin Agritech Limited


These press releases may also interest you

at 10:20
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005...

at 10:20
SecurityScorecard has been named a leader in The Forrester WaveTM: Cybersecurity Risk Ratings Platforms, Q2 2024. The report covers 10 vendors with cybersecurity risk ratings capabilities. SecurityScorecard received the highest score possible across...

at 10:19
Shared market leadership underscores strong partnership in Edge AI applications The Quadrant Knowledge Solutions SPARK Matrixtm provides competitive analysis and ranking of the leading Internet of Things (IoT) edge analytics platform...

at 10:16
According to a new market research report titled, 'Packaging Automation Market by Offering (Solution, Services), Type, End-use Industry (Healthcare & Pharmaceuticals, E-commerce & Logistics, Food & Beverage, Chemical & Refinery, Aerospace & Defense),...

at 10:15
Inverness Graham ("IGI"), a Philadelphia based buyout firm that acquires innovative companies where technology is transforming traditional industry, is pleased to announce the sale of Swipeclock, a leading provider of cloud-based integrated human...

at 10:15
AI, VR/AR, and EdTech developments will power smart learning in the future by allowing individualized, immersive, and adaptable learning opportunities. Prioritizing lifelong learning, online and hybrid learning, and data security will increase global...



News published on and distributed by: